论文部分内容阅读
2型糖尿病患者50名,采用随机、弥可保(依帕司他:弥可保=1∶1)平行对照的临床研究方法。结果:三个月并与弥可保对照,证明依帕司他能明显改善周围神经病变的自觉症状及体征,疗效与弥可保相似。结论:依帕司他对治疗糖尿病周围神经病变是一种安全、有效的药物。
Fifty patients with type 2 diabetes were randomized to receive a parallel clinical trial of methystola (epalrestat: methycobal = 1: 1). Results: Three months and compared with methycobalamin, prove that epalrestat can significantly improve the symptoms and signs of peripheral neuropathy, the effect is similar with the cancock. Conclusion: Epalrestat is a safe and effective drug for the treatment of diabetic peripheral neuropathy.